Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'HIV-INFECTED PATIENTS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 824 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Skiest, DJ
      Focal neurological disease in patients with acquired immunodeficiency syndrome

      CLINICAL INFECTIOUS DISEASES
    2. Andreoletti, L; Lescieux, A; Lambert, V; Si-Mohamed, A; Matta, M; Wattre, P; Belec, L
      Semiquantitative detection of JCV-DNA in peripheral blood leukocytes from HIV-1-Infected patients with or without Progressive Multifocal Leukoencephalopathy

      JOURNAL OF MEDICAL VIROLOGY
    3. Midulla, F; Strappini, P; Sandstrom, T; Bjermer, L; Falasca, C; Capocaccia, P; Catania, S; Soldi, E; Villa, MP; Ronchetti, R
      Cellular and noncellular components of bronchoalveolar lavage fluid in HIV-1-infected children with radiological evidence of interstitial lung damage

      PEDIATRIC PULMONOLOGY
    4. Salmaggi, A; Maccagnano, E; Castagna, A; Zeni, S; Fantini, F; Cinque, P; Savoiardo, M
      Reversal of CSF positivity for JC virus genome by cidofovir in a patient with systemic lupus erythematosus and progressive multifocal leukoencephalopathy

      NEUROLOGICAL SCIENCES
    5. Meroni, L; Manganaro, D; Varchetta, S; Gatti, N; Riva, A; Monforte, AD; Galli, M
      Maintenance of naive and Th1CD4 phenotype and lack of CD8 activation in patients switching from protease inhibitors to nonnucleoside reverse transcriptase inhibitor-based antiretroviral regimens

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    6. Carrieri, P; Cailleton, V; Le Moing, V; Spire, B; Dellamonica, P; Bouvet, E; Raffi, F; Journot, V; Moatti, JP
      The dynamic of adherence to highly active antiretroviral therapy: Results from the French National APROCO cohort

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    7. Lafeuillade, A; Poggi, C; Chadapaud, S; Hittinger, G; Chouraqui, M; Delbeke, E
      HIV-1 induction-maintenance at the lymph node level: The "Apollo-97" study

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    8. Tozzi, V; Balestra, T; Galgani, S; Narciso, P; Sampaolesi, A; Antinori, A; Giulianelli, M; Serraino, I; Ippolito, G
      Changes in neurocognitive performance in a cohort of patients treated withHAART for 3 years

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    9. Altice, FL; Mostashari, F; Friedland, GH
      Trust and the acceptance of and adherence to antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    10. Nunez, M; Lana, R; Mendoza, JL; Martin-Carbonero, L; Soriano, V
      Risk factors for severe hepatic injury after introduction of highly activeantiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    11. Jensen-Fangel, S; Thomsen, HF; Larsen, L; Black, FT; Obel, N
      The effect of nevirapine in combination with nelfinavir in heavily pretreated HIV-1-infected patients - A prospective, open-label, controlled, randomized study

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    12. Marimoutou, C; Chene, G; Mercie, P; Neau, D; Farbos, S; Morlat, P; Ceccaldi, J; Dabis, F
      Prognostic factors of combined viral load and CD4(+) cell count responses under triple antiretroviral therapy, aquitaine cohort, 1996-1998

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    13. Coull, JJ; Turner, D; Melby, T; Betts, MR; Lanier, R; Margolis, DM
      A pilot study of the use of mycophenolate mofetil as a component of therapy for multidrug-resistant HIV-1 infection

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    14. Lafeuillade, A; Poggi, C; Chadapaud, S; Hittinger, G; Chouraqui, M; Pisapia, M; Delbeke, E
      Pilot study of a combination of highly active antiretroviral therapy and cytokines to induce HIV-1 remission

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    15. Loveday, C
      Nucleoside reverse transcriptase inhibitor resistance

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    16. Sasadeusz, J
      Human immunodeficiency virus-hepatitis C coinfection: swapping new problems for newer ones

      INTERNAL MEDICINE JOURNAL
    17. Pett, SL; Emery, S
      Immunomodulators as adjunctive therapy for HIV-1 infection

      JOURNAL OF CLINICAL VIROLOGY
    18. Garcia-Lerma, JG; Heneine, W
      Resistance of human immunodeficiency virus type 1 to reverse transcriptaseand protease inhibitors: genotypic and phenotypic testing

      JOURNAL OF CLINICAL VIROLOGY
    19. Le Monte, AM; Goldman, M; Smedema, ML; Connolly, PA; McKinsey, DS; Cloud, GA; Kauffman, CA; Wheat, LJ
      DNA fingerprinting of serial Candida albicans isolates obtained during itraconazole prophylaxis in patients with AIDS

      MEDICAL MYCOLOGY
    20. Taylor, S; Pereira, AS
      Antiretroviral drug concentrations in semen of HIV-1 infected men

      SEXUALLY TRANSMITTED INFECTIONS
    21. Nieuwkerk, P; Gisolf, E; Sprangers, M; Danner, S
      Adherence over 48 weeks in an antiretroviral clinical trial: variable within patients, affected by toxicities and independently predictive of virological response

      ANTIVIRAL THERAPY
    22. John, M; Nolan, D; Mallal, S
      Antiretroviral therapy and the lipodystrophy syndrome

      ANTIVIRAL THERAPY
    23. Foudraine, NA; Jurriaans, S; Weverling, GJ; Burger, DM; Hoetelmans, RMW; Roos, MTL; Maas, J; Miedema, F; Reiss, P; Portegies, P; de Wolf, F; Lange, JMA
      Durable HIV-1 suppression with indinavir after failing lamivudine-containing double nucleoside therapy: a randomized controlled trial

      ANTIVIRAL THERAPY
    24. Squires, KE
      An introduction to nucleoside and nucleotide analogues

      ANTIVIRAL THERAPY
    25. Hoetelmans, R
      Pharmacological exposure and the development of drug resistance in HIV

      ANTIVIRAL THERAPY
    26. Scully, C; Dios, PD
      Orofacial effects of antiretroviral therapies

      ORAL DISEASES
    27. Hube, B; Naglik, J
      Candida albicans proteinases: resolving the mystery of a gene family

      MICROBIOLOGY-SGM
    28. Abbott, KC; Hypolite, I; Welch, PG; Agodoa, LYC
      Human immunodeficiency virus/acquired immunodeficiency syndrome-associatednephropathy at end-stage renal disease in the United States: patient characteristics and survival in the pre highly active antiretroviral therapy era

      JOURNAL OF NEPHROLOGY
    29. Knobel, H; Guelar, A; Carmona, A; Espona, M; Gonzalez, A; Lopez-Colomes, JL; Saballs, P; Gimeno, JL; Diez, A
      Virologic outcome and predictors of virologic failure of highly active antiretroviral therapy containing protease inhibitors

      AIDS PATIENT CARE AND STDS
    30. Engberg, J; Aarestrup, FM; Taylor, DE; Gerner-Smidt, P; Nachamkin, I
      Quinolone and macrolide resistance in Campylobacter jejuni and C-coli: Resistance mechanisms and trends in human isolates

      EMERGING INFECTIOUS DISEASES
    31. Uchakin, PN; Tobin, B; Cubbage, M; Marshall, G; Sams, C
      Immune responsiveness following academic stress in first-year medical students

      JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    32. Takii, T; Abe, C; Tamura, A; Ramayah, S; Belisle, JT; Brennan, PJ; Onozaki, K
      Interleukin-1 or tumor necrosis factor-alpha augmented the cytotoxic effect of mycobacteria on human fibroblasts: Application to evaluation of pathogenesis of clinical isolates of Mycobacterium tuberculosis and M-avium complex

      JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    33. Wootton, JC; Sparber, A
      Surveys of complementary and alternative medicine: Part III. Use of alternative and complementary therapies for HIV/AIDS

      JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE
    34. Blazevic, V; Jankelevich, S; Steinberg, SM; Jacobsen, F; Yarchoan, R; Shearer, GM
      Highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children: Analysis of cellular immune responses

      CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
    35. John, L; Marra, F; Ensom, MHH
      Role of therapeutic drug monitoring for protease inhibitors

      ANNALS OF PHARMACOTHERAPY
    36. Ally, R; Schurmann, D; Kreisel, W; Carosi, G; Aguirrebengoa, K; Dupont, B; Hodges, M; Troke, P; Romero, AJ
      A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients

      CLINICAL INFECTIOUS DISEASES
    37. Kilby, JM
      Human immunodeficiency virus pathogenesis: Insights from studies of lymphoid cells and tissues

      CLINICAL INFECTIOUS DISEASES
    38. McNeil, MM; Nash, SL; Hajjeh, RA; Phelan, MA; Conn, LA; Plikaytis, BD; Warnock, DW
      Trends in mortality due to invasive mycotic diseases in the United States,1980-1997

      CLINICAL INFECTIOUS DISEASES
    39. Tudo, G; Gonzalez, J; Gatell, JM; Cayla, JA; Martinez, E; Garcia, A; Navarro, M; Soriano, E; de Anta, MTJ
      Detection of unsuspected cases of nosocomial transmission of tuberculosis by use of a molecular typing method

      CLINICAL INFECTIOUS DISEASES
    40. Duong, M; Piroth, L; Peytavin, G; Forte, F; Kohli, E; Grappin, M; Buisson, M; Chavanet, P; Portier, H
      Value of patient self-report and plasma human immunodeficiency virus protease inhibitor level as markers of adherence to antiretroviral therapy: Relationship to virologic response

      CLINICAL INFECTIOUS DISEASES
    41. Cruciani, M; Malena, M; Bosco, O; Gatti, G; Serpelloni, G
      The impact of human immunodeficiency virus type 1 on infectiousness of tuberculosis: A meta-analysis

      CLINICAL INFECTIOUS DISEASES
    42. Abgrall, S; Rabaud, C; Costagliola, D
      Incidence and risk factors for toxoplasmic encephalitis in human immunodeficiency virus-infected patients before and during the highly active antiretroviral therapy era

      CLINICAL INFECTIOUS DISEASES
    43. Driver, CR; Munsiff, SS; Li, JH; Kundamal, N; Osahan, SS
      Relapse in persons treated for drug-susceptible tuberculosis in a population with high coinfection with human immunodeficiency virus in New York City

      CLINICAL INFECTIOUS DISEASES
    44. Warren, DK; Foley, KM; Polish, LB; Seiler, SM; Fraser, VJ
      Tuberculin skin testing of physicians at a midwestern teaching hospital: A6-year prospective study

      CLINICAL INFECTIOUS DISEASES
    45. Fleisch, F; Zbinden, R; Vanoli, C; Ruef, C
      Epidemic spread of a single clone of methicillin-resistant Staphylococcus aureus among injection drug users in Zurich, Switzerland

      CLINICAL INFECTIOUS DISEASES
    46. Sereti, I; Lane, HC
      Immunopathogenesis of human immunodeficiency virus: Implications for immune-based therapies

      CLINICAL INFECTIOUS DISEASES
    47. Shevitz, AH; Knox, TA
      Nutrition in the era of highly active antiretroviral therapy

      CLINICAL INFECTIOUS DISEASES
    48. Walmsley, S; King, S; McGeer, A; Ye, YN; Richardson, S
      Oropharyngeal candidiasis in patients with human immunodeficiency virus: Correlation of clinical outcome with in vitro resistance, serum azole levels, and immunosuppression

      CLINICAL INFECTIOUS DISEASES
    49. Simdon, J; Watters, D; Bartlett, S; Connick, E
      Ototoxicity associated with use of nucleoside analog reverse transcriptaseinhibitors: A report of 3 possible cases and review of the literature

      CLINICAL INFECTIOUS DISEASES
    50. Bersoff-Matcha, SJ; Miller, WC; Aberg, JA; van der Horst, C; Hamrick, HJ; Powderly, WG; Mundy, LM
      Sex differences in nevirapine rash

      CLINICAL INFECTIOUS DISEASES
    51. Stylianou, E; Aukrust, P; Muller, F; Nordoy, I; Froland, SS
      Complex effects of interferon-alpha on the cytokine network in HIV infection - Possible contribution to immunosuppression

      CYTOKINE
    52. Calarota, SA; Kjerrstrom, A; Islam, KB; Wahren, B
      Gene combination raises broad human immunodeficiency virus-specific cytotoxicity

      HUMAN GENE THERAPY
    53. Geretti, AM; Easterbrook, P
      Antiretroviral resistance in clinical practice

      INTERNATIONAL JOURNAL OF STD & AIDS
    54. Manfredi, R; Chiodo, F
      Switch of protease inhibitor-containing HAART in routine clinical practice: a four-year prospective observational study

      INTERNATIONAL JOURNAL OF STD & AIDS
    55. Skiest, DJ; Chiller, T; Chiller, K; Park, A; Keiser, P
      Protease inhibitor therapy is associated with markedly prolonged time to relapse and improved survival in AIDS patients with cytomegalovirus retinitis

      INTERNATIONAL JOURNAL OF STD & AIDS
    56. Bang, D; Emborg, J; Elkjaer, J; Lundgren, JD; Benfield, TL
      Independent risk of mechanical ventilation for AIDS-related Pneumocystis carinii pneumonia associated with bronchoalveolar lavage neutrophilia

      RESPIRATORY MEDICINE
    57. Stellbrink, HJ; van Lunzen, J
      Lymph nodes during antiretroviral therapy

      CURRENT OPINION IN INFECTIOUS DISEASES
    58. Macias, J; Pineda, JA; Leal, M; Abad, MA; Delgado, J; Rosa, R; Rubio, A; Sanchez-Quijano, A; Lissen, E
      HIV-1 plasma viremia not increased in patients receiving highly active antiretroviral therapy after influenza vaccination

      EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
    59. Bastert, J; Schaller, M; Korting, HC; Evans, EGV
      Current and future approaches to antimycotic treatment in the era of resistant fungi and immunocompromised hosts

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    60. Jacobson, LP; Gore, ME; Strathdee, SA; Phair, JP; Riddler, S; Detels, R
      Therapy naivete in the era of patent antiretroviral therapy

      JOURNAL OF CLINICAL EPIDEMIOLOGY
    61. Goodgame, RW
      Viral causes of diarrhea

      GASTROENTEROLOGY CLINICS OF NORTH AMERICA
    62. Nunez, M; Rodriguez-Rosado, R; Soriano, V
      Intensification of antiretroviral therapy

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    63. Casado, JL; Dronda, F; Hertogs, K; Sabido, R; Antela, A; Marti-Belda, P; Dehertogh, P; Moreno, S
      Efficacy, tolerance, and pharmacokinetics of the combination of stavudine,nevirapine, nelfinavir, and saquinavir as salvage regimen after ritonavir or indinavir failure

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    64. Quiros-Roldan, E; Moretti, F; Airoldi, M; Fausti, C; Chiodera, A; Castelli, F; Carosi, G
      Long-term benefit of genotypic-guided therapy and prevalence of multinucleoside resistance in an Italian group of antiretroviral multiexperienced patients

      JOURNAL OF CLINICAL LABORATORY ANALYSIS
    65. Palepu, A; Tyndall, MW; Leon, H; Muller, J; O'Shaughnessy, MV; Schechter, MT; Anis, AH
      Hospital utilization and costs in a cohort of injection drug users

      CANADIAN MEDICAL ASSOCIATION JOURNAL
    66. Pomerantz, RJ
      Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy

      BIOMEDICINE & PHARMACOTHERAPY
    67. Capini, CJ; Richardson, MW; Hendel, H; Sverstiuk, A; Mirchandani, J; Regulier, EG; Khalili, K; Zagury, JF; Rappaport, J
      Autoantibodies to TNF alpha in HIV-1 infection: prospects for anti-cytokine vaccine therapy

      BIOMEDICINE & PHARMACOTHERAPY
    68. Burman, WJ; Gallicano, K; Peloquin, C
      Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials

      CLINICAL PHARMACOKINETICS
    69. Tran, JQ; Gerber, LG; Kerr, BM
      Delavirdine - Clinical pharmacokinetics and drug interactions

      CLINICAL PHARMACOKINETICS
    70. Buss, N; Snell, P; Bock, J; Hsu, A; Jorga, K
      Saquinavir and ritonavir pharmacokinetics following combined ritonavir andsaquinavir (soft gelatin capsules) administration

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    71. Diagbouga, S; Chiron, JP; Sanou, O; Ledru, E
      Alteration in CD29(high) CD4(+) lymphocyte subset is a common feature of early HIV disease and of active tuberculosis

      SCANDINAVIAN JOURNAL OF IMMUNOLOGY
    72. Michel, ML; Loirat, D
      DNA vaccines for prophylactic or therapeutic immunization against hepatitis B

      INTERVIROLOGY
    73. Dorne, JLCM; Walton, K; Renwick, AG
      Human variability in glucuronidation in relation to uncertainty factors for risk assessment

      FOOD AND CHEMICAL TOXICOLOGY
    74. Klepser, ME
      Antifungal resistance among Candida species

      PHARMACOTHERAPY
    75. Di Martino, V; Rufat, P; Boyer, N; Renard, P; Degos, F; Martinot-Peignoux, M; Matheron, S; Le Moing, V; Vachon, F; Degott, C; Valla, D; Marcellin, P
      The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: A long-term retrospective cohort study

      HEPATOLOGY
    76. Benhamou, Y; Di Martino, V; Bochet, M; Colombet, G; Thibault, V; Liou, A; Katlama, C; Poynard, T
      Factors affecting liver fibrosis in human immunodeficiency virus- and hepatitis C virus-coinfected patients: Impact of protease inhibitor therapy

      HEPATOLOGY
    77. Kostense, S; Raaphorst, FM; Joling, J; Notermans, DW; Prins, JM; Danner, SA; Reiss, P; Lange, JMA; Teale, JM; Miedema, F
      T cell expansions in lymph nodes and peripheral blood in HIV-1-infected individuals: effect of antiretroviral therapy

      AIDS
    78. Grelli, S; Di Traglia, L; Matteucci, C; Lichtner, M; Vullo, V; Di Sora, F; Lauria, F; Montella, F; Favalli, C; Vella, S; Macchi, B; Mastino, A
      Changes in apoptosis after interruption of potent antiretroviral therapy in patients with maximal HIV-1-RNA suppression

      AIDS
    79. Yamashita, TE; Phair, JP; Munoz, A; Margolick, JB; Detels, R; O'Brien, SJ; Mellors, JW; Wolinsky, SM; Jacobson, LP
      Immunologic and virologic response to highly active antiretroviral therapyin the Multicenter AIDS Cohort Study

      AIDS
    80. Arendt, G; Giesen, HJV; Hefter, H; Theisen, A
      Therapeutic effects of nucleoside analogues on psychomotor slowing in HIV infection

      AIDS
    81. Mocroft, A; Phillips, AN; Miller, V; Gatell, J; van Lunzen, J; Parkin, JM; Weber, R; Roge, B; Lazzarin, A; Lundgren, JD
      The use of and response to second-line protease inhibitor regimens: results from the EuroSIDA study

      AIDS
    82. Grant, LA; Silverberg, MJ; Palacio, H; Minkoff, H; Anastos, K; Young, MA; Nowicki, M; Kovacs, A; Cohen, M; Munoz, A
      Discontinuation of potent antiretroviral therapy: predictive value of and impact on CD4 cell counts and HIV RNA levels

      AIDS
    83. Saag, MS; Tebas, P; Sension, M; Conant, M; Myers, R; Chapman, SK; Anderson, R; Clendeninn, N
      Randomized, double-blind comparison of two nelfinavir doses plus nucleosides in HIV-infected patients (Agouron study 511)

      AIDS
    84. Lucas, GM; Chaisson, RE; Moore, RD
      Comparison of initial combination antiretroviral therapy with a single protease inhibitor, ritonavir and saquinavir, or efavirenz

      AIDS
    85. Neau, D; Trimoulet, P; Winnock, M; Le Bail, B; Schvoerer, E; Legrand, E; Ragnaud, JM; Dupon, M; Fleury, H; Lafon, ME
      Impact of protease inhibitors on intrahepatic hepatitis C virus viral load

      AIDS
    86. Koletar, SL; Heald, AE; Finkelstein, D; Hafner, R; Currier, JS; McCutchan, JA; Vallee, M; Torriani, FJ; Powderly, WG; Fass, RJ; Murphy, RL
      A prospective study of discontinuing primary and secondary Pneumocystis carinii pneumonia prophylaxis after CD4 cell count increase to > 200 X 10(6)/I

      AIDS
    87. Pomerantz, RJ
      Residual HIV-1 infection during antiretroviral therapy: the challenge of viral persistence

      AIDS
    88. Saag, MS
      The impact of highly active antiretroviral therapy on HIV-specific immune function

      AIDS
    89. Betti, M; Voltan, R; Marchisio, M; Mantovani, I; Boarini, C; Nappi, F; Ensoli, B; Caputo, A
      Characterization of HIV-1 Tat proteins mutated in the transactivation domain for prophylactic and therapeutic application

      VACCINE
    90. Bossi, P; Martinez, V; Strady, C; Bricaire, F
      Antiretroviral treatments in 2000

      REVUE DE MEDECINE INTERNE
    91. Cesteros, RI; Menasalvas, AI; Guerrero, C; Lopez-Dominguez, R; Miranda, A; Segovia, M
      Bacteremia due to Campylobacter jejuni: Report of two cases

      ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
    92. Trevino, M; Prieto, E; Penalver, D; Aguilera, A; Garcia-Zabarte, A; Garcia-Riestra, C; Regueiro, BJ
      Adenovirus and astrovirus diarrhea in immunocompromised hospitalized patients

      ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
    93. Hannan, MM; Peres, H; Maltez, F; Hayward, AC; Machado, J; Morgado, A; Proenca, R; Nelson, MR; Bico, J; Young, DB; Gazzard, BS
      Investigation and control of a large outbreak of multi-drug resistant tuberculosis at a central Lisbon hospital

      JOURNAL OF HOSPITAL INFECTION
    94. Dodig, M; Tavill, AS
      Hepatitis C and human immunodeficiency virus coinfections

      JOURNAL OF CLINICAL GASTROENTEROLOGY
    95. Weinmann, M; Becker, G; Einsele, H; Bamberg, M
      Clinical indications and biological mechanisms of splenic irradiation in autoimmune diseases

      STRAHLENTHERAPIE UND ONKOLOGIE
    96. Jain, RG; Furfine, ES; Pedneault, L; White, AJ; Lenhard, JM
      Metabolic complications associated with antiretroviral therapy

      ANTIVIRAL RESEARCH
    97. Schurmann, D; Bergmann, F; Albrecht, H; Padberg, J; Grunewald, T; Behnsch, M; Grobusch, M; Vallee, M; Wunsche, T; Ruf, B; Suttorp, N
      Twice-weekly pyrimethamine-sulfadoxine effectively prevents Pneumocystis carinii pneumonia relapse and toxoplasmic encephalitis in patients with AIDS

      JOURNAL OF INFECTION
    98. Pellegrin, I; Breilh, D; Birac, V; Deneyrolles, M; Mercie, P; Trylesinski, A; Neau, D; Saux, MC; Fleury, HJA; Pellegrin, JL
      Pharmacokinetics and resistance mutations affect virologic response to ritonavir/saquinavir-containing regimens

      THERAPEUTIC DRUG MONITORING
    99. Duong, M; Buisson, M; Cottin, Y; Piroth, L; Lhuillier, I; Grappin, M; Chavanet, P; Wolff, JE; Portier, H
      Coronary heart disease associated with the use of human immunodeficiency virus (HIV)-1 protease inhibitors: Report of four cases and review

      CLINICAL CARDIOLOGY
    100. Amendola, A; Boschini, A; Colzani, D; Anselmi, G; Oltolina, A; Zucconi, R; Begnini, M; Besana, S; Tanzi, E; Zanetti, AR
      Influenza vaccination of HIV-1-positive and HIV-1-negative former intravenous drug users

      JOURNAL OF MEDICAL VIROLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 19/02/20 alle ore 14:38:31